Premium
AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE TREATMENT OF HYPERCALCEMIC CRISIS DUE TO PRIMARY HYPERPARATHYROIDISM
Author(s) -
EVANS R. A.
Publication year - 1987
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1987.tb05052.x
Subject(s) - medicine , primary hyperparathyroidism , parathyroidectomy , hyperparathyroidism , surgery , gastroenterology , calcium , parathyroid hormone
A 43 year old man was known to have had mild primary hyperparathyroidism for several years. Nine days following surgery for acute cholecystitis he developed a hypercalcemic crisis with a plasma calcium level of 4.23 mmol/l, despite intravenous and oral hydration. The hypercalcemia was corrected by a single intravenous dose of (3‐amino‐1‐hydroxypropylidene)‐1,1‐diphosphonate (15 mg), allowing parathyroidectomy to be performed electively and on a well patient.